These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 10532606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Performance characteristics of the COBAS AmpliScreen HIV-1 test, version 1.5, an assay designed for screening plasma mini-pools.
    Yang Y, Lamendola MH, Mendoza M, Xu D, Nguyen M, Yeh S, Wu Y, Ku J, Rosenstraus M, Sun R.
    Transfusion; 2001 May; 41(5):643-51. PubMed ID: 11346701
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F, Henriques I, Monteiro F, Meireles E, Cruz A, Tavares G, Mota-Miranda A.
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [Abstract] [Full Text] [Related]

  • 6. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN.
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
    Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP.
    Transfusion; 2003 Feb; 43(2):215-25. PubMed ID: 12559017
    [Abstract] [Full Text] [Related]

  • 13. Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples.
    Adami V, Falasca E, Dorotea L, Malangone W, Astori G, Marini L, Biffoni F, Rinaldi C, Degrassi A, Pipan C.
    Clin Microbiol Infect; 2004 Dec; 10(12):1075-80. PubMed ID: 15606634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT.
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [Abstract] [Full Text] [Related]

  • 16. Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.
    Grabarczyk P, Koppelman M, Boland F, Sauleda S, Fabra C, Cambie G, Kopacz A, O'Riordan K, van Drimmelen H, O'Riordan J, Lelie N.
    Transfusion; 2015 Sep; 55(9):2246-55. PubMed ID: 26103564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research GroupJapanese Red Cross Plasma Fractionation Center, Tokyo 105-0013, Japan..
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [Abstract] [Full Text] [Related]

  • 19. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
    Grabarczyk P, van Drimmelen H, Kopacz A, Gdowska J, Liszewski G, Piotrowski D, Górska J, Kuśmierczyk J, Candotti D, Lętowska M, Lelie N, Brojer E.
    Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
    [Abstract] [Full Text] [Related]

  • 20. Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA.
    Mueller J, Gessner M, Remberg A, Hoch J, Zerlauth G, Hanfland P.
    Clin Chem Lab Med; 2005 Oct; 43(8):827-33. PubMed ID: 16201892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.